Yan Leyfman, MD

Yan Leyfman, MD has been a member of Linktree for 6 years and joined in July 2020. The social media accounts linked to from Yan Leyfman, MD are: • LinkedIn • X Besides social media accounts, yleyfman has populated their site with: • Oncology Times I From Ashes to Hope A Physician's Journey • MedNews Week and OncLive® forge partnership to advance global health care education • MedNews Week | OncLive Channel • MedNews Week | Youtube Video Library • MedNews Week | VuMedi Video Library • Connect with MedNews Week on all platforms • Oncology Data Advisor Interview | MedNews Week's Impact to Expand Global Health Education • Interview about MedNews Week | OncData | ASCO 2023 • NY Times: A Passion for Oncology from a Chernobyl Survivor • Marquis Who's Who Honors Yan Leyfman for Expertise in Health Care, Research, Education and Development • 2023 Nassau County Medical Society Member of the Month (Oct 2023) • OncLive Interviews • Recognized as 2023 40 Under 40 Emerging Leader in Oncology • 2023 Emerging Leaders in Oncology | 40 Under 40 in Cancer | Yan Leyfman Recognized • 40 Under 40 to Know in Cancer Care • 2023 Global Healthcare Hero | Leukemia, Lymphoma & Myeloma Congress • 2023 ASCO Conquer Cancer Merit & Abstract Award Recipient | Top 40 Globally • 2022 Heroes in Healthcare List • 2022 Hero in Healthcare- Lymphoma, Leukemia & Myeloma Congress • MSKCC Recognizes Yan Leyfman for Research Excellence • Recognized for Research Excellence by Memorial Sloan Kettering Cancer Center • City & State: Manhattan Heroes | Yan Leyfman Recognized for COVID-19 Research • Conquer Cancer announces 2023 Breakthrough Merit and Abstract Award Recipients | Conquer Cancer, the ASCO Foundation • Recognized as a 2020 Manhattan COVID-19 Hero • 36 Under 36 in 2020 • Student Innovator of the Year • 2021 Hero in Healthcare at the 2021 Lymphoma, Leukemia & Myeloma Congress • COVID-19 Pandemic Hero (Stony Brook University) • Researcher of the Month (Stony Brook University) • Radioactive Resilience: A Surv… - OncTimes Talk - Apple Podcasts • OncoDaily TV: Advancing Cancer Research Transforming Patient Care • ASCO's Conquer Cancer-- A Chernobyl Survivor's Tale to Pioneer Novel Anti-Cancer Therapies- Dr. Yan Leyfman • HumanityRx Podcast- Dr Yan Leyfman: Chernobyl Survivor & Oncologist • ABC15 Interview- DrConnect: CAR T Cell Therapy • Healthcare Podcast: My Passion for Patient Care • Medicine Beyond the Science: From Surviving Chernobyl to Tackling COVID-19 • Insight on Dasatinib CRL in CML/ALL | CancerNetwork • Cancer Network Interview: Exploring Personalized T-Cell Lymphoma Strategies • Cancer Network Interview: Ascertaining AI's Role in Cancer Diagnosis and Treatment • ONCOLOGY GO Podcast - Leveraging Artificial Intelligence to Bolster Equitable Cancer Care • Health Design Podcast: From Chernobyl to Cancer & COVID-19 along with a passion for global education & patient centered medical care • CLL Society | Surviving Chernobyl: The Incredible Story of Dr. Yan Leyfman • Larvol & Friends Podcast 2022- Immunotherapy: Where We Are & Where We are Going • Global Cancer Conference- Featured Speaker- A Chernobyl Survivor's Tale • The Doctor Connect Podcast: News about CAR T Cell Therapy • CLL Society | Promising Anti-COVID-19 Therapies on the Horizon • The Rope of Hope Podcast: Surviving The Side Effects of Chernobyl • AI Exosphere: A Discussion about Mentorship, AI, Cancer & COVID-19 • Larvol & Friends Podcast 2021: COVID-19, COVI-Flu, and Present State of the Pandemic • 2021 ASCO Abstract | First Mechanism to Explain the Interplay between Cancer & COVID-19 with a Promising Therapeutic Intervention • Cancer and COVID-19: The Immunological Mechanism with a Promising Therapeutic Interplay - Journal of Hematology & Oncology • 2021 ASCO Abstract Published in Journal of Clinical Oncology • Life Sciences Success Podcast- Discussion about my Background, Passion for Medicine, Research Contributions & 2021 ASCO Research Presentation • 2021 ASH Meeting | Social Media Validation for Pre-Screened Ontologies As a Driver for Biomolecular Interaction Significance in COVID-19 and Hematological Malignancies | Blood | American Society of Hematology • 2022 ASCO Meeting | Tackling healthcare inequities through a social media-based platform to connect solid tumor patients with COVID-19 to clinical trials • 2022 ASCO Meeting | Longitudinal immunological responses of COVID-19 vaccination in patients with solid tumors on active treatment: A pilot study. • KYSCO's Expert Rounds Podcast: "Cancer, COVID-19 & Long COVID: Unraveling the Immunological Paradigm" • Research Presentation on CAR T Cells (iCHEM 2020 Immunology & Immunotherapy Meeting) • Research Presentation on Marginal Zone Lymphoma of the Lung (ASCO 2020) • [Book Chapter] Immunotherapy in Sarcoma: Where do Things Stand? • Oncology Research: New Treatment Recommendations for Low Grade BALT • Oncology Research: New Generation Therapy Shows Efficacy Against Solid Tumors • Oncology Research: Cancer Stem Cell Genomic Analysis • Immunotherapy Research: Unleashing a New Age of Immunotherapeutics • Immunotherapy Research: New Assay to Enhance CAR T Cell Efficacy • COVID-19 Research: Mechanisms, Immunotherapeutic Targets & Preventative Strategies for COVID-19 & COVI-Flu • ↑↑ Video Interview about the above COVID-19 & COVI-Flu Publication ↑↑ • Video: Moderator in COVID-19 Vaccines Panel Discussion • I Survived Chernobyl, Now I’m Searching for a COVID-19 Treatment • COVID-19 Research: Largest International Anthology about COVID-19 • COVI-Flu Book Chapter • 2021 HITLAB Innovator's Summit | Featured Presentation | From Covid-19 to Covi-Flu: Diving Into the Immunological Paradigm • Photography Portfolio • Photography: My Passion for Photography Feature Article • Photography: My Feature Story about a Superwoman Cancer Survivor